Nano-LC for Proteomics

One of the challenges of proteomics is sample size. Researchers need to fractionate complex protein mixtures into their component parts for subsequent analysis, but the miniscule quantities and volumes involved preclude standard large-scale chromatography. Three years ago Agilent Technologies, headquartered in Palo Alto, Calif., introduced its 1100 series capillary LC system, featuring tiny tubes that could pump nanoliter volumes through columns with high accuracy. Now the company is following

Written byAparna Sreenivasan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

One of the challenges of proteomics is sample size. Researchers need to fractionate complex protein mixtures into their component parts for subsequent analysis, but the miniscule quantities and volumes involved preclude standard large-scale chromatography. Three years ago Agilent Technologies, headquartered in Palo Alto, Calif., introduced its 1100 series capillary LC system, featuring tiny tubes that could pump nanoliter volumes through columns with high accuracy. Now the company is following that up with a microfraction collection system for single or multidimensional separation of protein and peptide mixtures.

The new device features a low flow rate, lower fraction delay volumes, and an optimized nanoflow apparatus. "The standard HPLC uses flow rates of 1 ml per minute, while we go down to five to 500 nanoliters per minute," says Christian Gotenfels, product manager of the solutions group at Agilent Technologies labs in Waldbronn, Germany. To accommodate the small sample volumes used by proteomics ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies